<DOC>
	<DOCNO>NCT01028846</DOCNO>
	<brief_summary>The purpose study understand diazoxide , medication show effect insulin hormone secretion , regulate production sugar liver .</brief_summary>
	<brief_title>Central Mechanisms That Regulate Glucose Metabolism Humans</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diazoxide</mesh_term>
	<criteria>BP &lt; 130/90 ( +2 med ) BMI &lt; 35 Normal screen lab ( CBC , chemistry , lft 's PT/PTT ) No CAD No first degree relative history CAD MI ( men &lt; 45 ; woman &lt; 55 ) Good IV access Noth medical problem exception : HTN ( &lt; = 2 med ) , hypercholesterolemia , stable retinopathy Nonsmoker Hemoglobin A1C 7.511 BP &gt; 130/90 ( + medication ) BMI &gt; 35 Abnormal EKG History CAD exertional chest pain First degree relative early CAD MI Medications medical psychiatric condition include : dofetilide , fosphenytoin/phenytoin trichlormethiazide ( thiazide ) , chlorpromazine warfarin &lt; 4 week history participation another drug trial</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Type 2 Diabetes</keyword>
</DOC>